| Characteristic | 2014 | 2020 |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
June 2015
More information
Region
Worldwide
Survey time period
2014
Supplementary notes
* Oncology includes: alkaloids, alkylating agents, antimetabolites, anti-neoplastic monoclonal antibodies (MABs), cancer vaccines, cytotoxic antibiotics, hormonal therapies, platinum compounds, and other anticancer agents. It excludes antiemetics and anti-anemics used in chemotherapy-induced anemia. It also excludes interferons, immunostimulants, and immunosuppressants.
The values for 2020 are projections. The products are ranked by market share in 2020.
Citation formats
